Table 2.
Unadjusted mortality and complication rates of TAAAD
| Outcomes | White (N = 2520) | Black/African American (N = 848) | Hispanic (N = 310) | API (N = 146) | Other (N = 128) | P value |
|---|---|---|---|---|---|---|
| Discharge status, n (%) | ||||||
| Died | 438 (17) | 90 (11) | 38 (12) | 22 (15) | 14 (11) | <.0001 |
| Resource utilization | ||||||
| Length of stay, d, median (IQR) | 10 (6-16) | 11 (7-18) | 11 (7-17) | 11 (7-16) | 13.5 (7.5-23) | <.0001 |
| Total cost, USD, median (IQR) | 290,259 (195,413-459,875) | 291,043 (201,132-485,816) | 364,646 (252,824-634,016) | 291,469 (205,979-584,779) | 368,511 (231,915-620,019) | <.0001 |
| Complications | ||||||
| Any complication | 1142 (45) | 374 (44) | 138 (45) | 70 (48) | 70 (55) | .24 |
| Postprocedure shock/cardiac failure | 400 (16) | 110 (13) | 46 (15) | 32 (22) | 32 (25) | .002 |
| Pulmonary complications | 616 (24) | 240 (28) | 76 (25) | 28 (19) | 36 (28) | .07 |
| Hemorrhage/hematoma/seroma | 182 (7) | 72 (8) | 22 (7) | 8 (5) | 12 (9) | .55 |
| Stroke | 52 (2) | 12 (1) | 2 (1) | 4 (3) | 4 (3) | .22 |
| Adverse reaction | 430 (17) | 102 (12) | 42 (14) | 34 (23) | 34 (27) | <.0001 |
| Catheter-related complication | 14 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | .09 |
| Postprocedure hypertension | 14 (1) | 8 (1) | 6 (2) | 2 (1) | 0 (0) | .06 |
| Other unspecified complications | 24 (1) | 4 (0.5) | 2 (1) | 0 (0) | 0 (0) | .36 |
API, Asian and Pacific Islander; IQR, interquartile range; TAAAD, type A acute aortic dissection.